Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma

Bao,Zhaoshi; Feng,Ying; Wang,Hongjun; Zhang,Chuanbao; Sun,Lihua; Yan,Zhuohong; Liu,Qingyang; Guo,Tianzhu; Li,Mingyang; Yang,Xue; Jiang,Chuanlu; Zhang,Quangeng; Jiang,Tao

doi:10.3892/or.2014.3176

July-2014 Volume 32 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2014 Volume 32 Issue 1

Full Size Image

Article

Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma

Authors:
- Zhaoshi Bao
- Ying Feng
- Hongjun Wang
- Chuanbao Zhang
- Lihua Sun
- Zhuohong Yan
- Qingyang Liu
- Tianzhu Guo
- Mingyang Li
- Xue Yang
- Chuanlu Jiang
- Quangeng Zhang
- Tao Jiang
View Affiliations / Copyright

Affiliations: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Immunology, Institute of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China, Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China, Department of Neurosurgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China
Pages: 250-260
|
Published online on: May 15, 2014

https://doi.org/10.3892/or.2014.3176
Expand metrics +

Abstract

Hypermethylation of tumor suppressor promoters is generally accepted to indicate poor prognosis in glioma; however, the DNA methylation patterns associated with different glioma prognoses remain to be elucidated. In the present study, promoter methylation and gene expression microarrays were used to screen candidate genes between different grades of glioma. Survival analysis was performed using the Kaplan‑Meier (KM) method. Promoter methylation and protein expression of phosphodiesterase 4C (PDE4C) was examined in different grade gliomas and the correlation between PDE4C and wild-type (WT) p53 was evaluated in glioma cell lines. In addition, gene ontology and gene set variation analysis were used to examine PDE4C function. We found PDE4C exhibited promoter hypermethylation in high-grade glioma samples and hypomethylation in low-grade glioma, with PDE4C expression levels showing the reverse. This indicated PDE4C may be a candidate glioma biomarker. Through studies of PDE4C methylation and expression status in an independent cohort of 124 patient samples (56 low-grade and 63 high-grade glioma and 5 normal brain), we identified PDE4C as having significant promoter methylation and lower expression in high-grade glioma. Hypermethylation and reduced PDE4C protein expression were associated with grade progression and overall survival. In glioma cell lines, PDE4C was upregulated by demethylation treatment with 5-Aza-2'-deoxycytidine and WT p53 expression was downregulated after PDE4C siRNA suppression. Finally, we found PDE4C promoted apoptosis and inhibited migration in a U87 cell line. On the basis of these observations and the results from subset analysis, it is reasonable to conclude that PDE4C may function as a tumor suppressor by promoting apoptosis through the WT p53 pathway and inhibiting cell migration. The data show that PDE4C is downregulated through promoter hypermethylation in glioma.

View Figures

View References

1	Krex D, Klink B, Hartmann C, et al: Long-term survival with glioblastoma multiforme. Brain. 130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI
2	Zhang W, Yan W, You G, et al: Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer Lett. 328:120–125. 2013. View Article : Google Scholar : PubMed/NCBI
3	Maegawa S, Yoshioka H, Itaba N, et al: Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol Carcinog. 31:1–9. 2001.
4	van den Boom J, Wolter M, Kuick R, et al: Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol. 163:1033–1043. 2003.
5	Hu Y, Pioli PD, Siegel E, et al: EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer. 10:1232011. View Article : Google Scholar : PubMed/NCBI
6	He SM, Zhao ZW, Wang Y, et al: Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients. J Exp Clin Cancer Res. 30:702011. View Article : Google Scholar : PubMed/NCBI
7	Grønbaek K, Hother C and Jones PA: Epigenetic changes in cancer. APMIS. 115:1039–1059. 2007.
8	Naderi EH, Findley HW, Ruud E, Blomhoff HK and Naderi S: Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood. 114:608–618. 2009. View Article : Google Scholar : PubMed/NCBI
9	Foltz G, Ryu GY, Yoon JG, et al: Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res. 66:6665–6674. 2006. View Article : Google Scholar : PubMed/NCBI
10	Kim YJ, Yoon HY, Kim JS, et al: HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int J Cancer. 133:1135–1142. 2013. View Article : Google Scholar
11	Berdasco M, Ropero S, Setien F, et al: Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc Natl Acad Sci USA. 106:21830–21835. 2009. View Article : Google Scholar : PubMed/NCBI
12	Jin SL, Ding SL and Lin SC: Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Med J. 35:197–210. 2012.PubMed/NCBI
13	Beavo JA and Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 11:150–155. 1990. View Article : Google Scholar : PubMed/NCBI
14	Conti M, Jin SL, Monaco L, Repaske DR and Swinnen JV: Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocr Rev. 12:218–234. 1991. View Article : Google Scholar : PubMed/NCBI
15	Pérez-Torres S1, Miró X, Palacios JM, Cortés R, Puigdoménech P and Mengod G: Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[³H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat. 20:349–374. 2000.PubMed/NCBI
16	Naderi EH, Jochemsen AG, Blomhoff HK and Naderi S: Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2. Neoplasia. 13:653–663. 2011.PubMed/NCBI
17	Li S, Yan C, Huang L, Qiu X, Wang Z and Jiang T: Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China. Neuro Oncol. 14:109–116. 2012. View Article : Google Scholar : PubMed/NCBI
18	Hill VK, Ricketts C, Bieche I, et al: Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 71:2988–2999. 2011. View Article : Google Scholar : PubMed/NCBI
19	Cadieux B, Ching TT, VandenBerg SR and Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66:8469–8476. 2006. View Article : Google Scholar
20	Owens RJ, Lumb S, Rees-Milton K, et al: Molecular cloning and expression of a human phosphodiesterase 4C. Cell Signal. 9:575–585. 1997. View Article : Google Scholar : PubMed/NCBI
21	Czernicki T, Zegarska J, Paczek L, et al: Gene expression profile as a prognostic factor in high-grade gliomas. Int J Oncol. 30:55–64. 2007.PubMed/NCBI
22	Freije WA, Castro-Vargas FE, Fang Z, et al: Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64:6503–6510. 2004. View Article : Google Scholar : PubMed/NCBI
23	Takahashi H and Kouno J: Gene expression profiling of malignant gliomas by cDNA microarrays. Nihon Rinsho. 63(Suppl 9): 515–519. 2005.(In Japanese).
24	Yoshino A, Ogino A, Yachi K, et al: Gene expression profiling predicts response to temozolomide in malignant gliomas. Int J Oncol. 36:1367–1377. 2010. View Article : Google Scholar : PubMed/NCBI
25	Schatz P, Distler J, Berlin K and Schuster M: Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection. Nucleic Acids Res. 34:e592006. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Related Articles